Pfizer building’s column scare tests Midtown East’s biggest conversion bet
All eyes were on Midtown East last week after steel columns buckled inside the Pfizer building conversion project, forcing evacuations at the site and nearby buildings on Tuesday. The structural failures at 235 East 42nd Street — where Nathan Berman’s MetroLoft Management and investor David Werner are converting the pharmaceutical firm’s former headquarters into 1,600 apartments — captured national headlines and sparked surprise among industry players, as well as a probe by the city’s Department of Investigation into their cause. Though the building has since been stabilized, its near-collapse — and the spotlight it attracted — also raises questions about […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

America’s Top Architects: One 10 Studio Architects Brings
Cabin Comfort To A Contemporary Indianapolis Home

A clearer look at the listings caught up in Compass’
StreetEasy pushback

NYC turns up the heat on housing holdouts

Two Bushwick buildings reflect NY’s twisted
priorities

NY Dirt: Heat season returns with more HPD scrutiny, J-51
reboot

Frasers Property, Mitsubishi To Build Upscale Residential
Tower Along Singapore River

Protecting Capital Investments In Today’s Less Forgiving
Market

The 25 Best Places To Retire If You Love Arts, Fine Dining
And The Outdoors

How To Find The Best Retirement Place To Follow Your
Passions

Benedikt Taschen’s Sublime Renovation Of An Iconic
Mid-Century Home In Beverly Hills


